Heart Failure with Preserved, Mid-Range, and Reduced Ejection Fraction Across Health Care Settings: An Observational Study
Annemarijn R de Boer(Utrecht University), Frans H. Rutten(Utrecht University), Arno W. Hoes(University Medical Center Utrecht), Gerard C.M. Linssen(British Heart Foundation), Yvonne van Mourik(Utrecht University), Hans‐Peter Brunner‐La Rocca(Inserm), Ilonca Vaartjes(Utrecht University), Evelien ES van Riet(Utrecht University), Aisha Gohar(Utrecht University), Hester M. den Ruijter(Utrecht University), Michiel L. Bots(Utrecht University), Leandra J M Boonman-de Winter, Mark J Valk(Utrecht University), Jasper J. Brugts(Erasmus MC)
Cited by 28
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Guidelines on the management of valvular heart disease (version 2012)
|European Heart Journal|2012|3.6k